Compare ELVN & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELVN | HGTY |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2020 | N/A |
| Metric | ELVN | HGTY |
|---|---|---|
| Price | $25.42 | $12.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $41.00 | $14.00 |
| AVG Volume (30 Days) | ★ 1.5M | 117.6K |
| Earning Date | 11-12-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 241.11 |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $1,360,017,000.00 |
| Revenue This Year | N/A | $18.41 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $35.99 |
| Revenue Growth | N/A | ★ 17.92 |
| 52 Week Low | $13.30 | $8.03 |
| 52 Week High | $29.98 | $14.00 |
| Indicator | ELVN | HGTY |
|---|---|---|
| Relative Strength Index (RSI) | 71.40 | 42.50 |
| Support Level | $23.25 | $12.63 |
| Resistance Level | $29.98 | $13.28 |
| Average True Range (ATR) | 1.98 | 0.44 |
| MACD | 1.30 | -0.08 |
| Stochastic Oscillator | 70.12 | 11.33 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.